Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Ulcerative Colitis Clinical Trials

104 recruiting trials for Ulcerative Colitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
104
Total Trials
104
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04751396

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for...

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 1251 location
RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT04191395

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points....

Sponsor: Centre Hospitalier Universitaire de BesanconEnrolling: 30001 location
RECRUITINGNCT04178408

IBD Registry in a Sub-Saharan African Population

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will...

Sponsor: University of ZimbabweEnrolling: 1001 location
RECRUITINGNCT06094608

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.

Sponsor: University of MichiganEnrolling: 681 location
RECRUITINGPhase 1 / Phase 2NCT03847467

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF...

Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1163 locations
RECRUITINGNCT06581042

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease...

Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. Ulcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting...

Sponsor: AbbVieEnrolling: 2807 locations
RECRUITINGNCT07421258

A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease...

Inflammatory Bowel Disease (IBD), encompassing Crohn's Disease (CD) and Ulcerative Colitis (UC), is a chronic, relapsing, and often disabling condition characterized by...

Sponsor: AbbVieEnrolling: 20004 locations
RECRUITINGNCT04912999

Inflammatory Bowel Diseases Remission Registry

The inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD), are characterized by lifelong relapsing-remitting gastrointestinal inflammation, with...

Sponsor: Tel-Aviv Sourasky Medical CenterEnrolling: 10001 location
RECRUITINGPhase 4NCT06113913

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

The goal of this clinical trial is to learn about the treatment with subcutaneous infliximab in patients with inflammatory bowel disease (IBD) that were previously treated with an...

Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZWEnrolling: 27515 locations
RECRUITINGPhase 3NCT05442567

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous...

Sponsor: TakedaEnrolling: 24020 locations
RECRUITINGNCT03809728

IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE

Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 10001 location
RECRUITINGPhase 2 / Phase 3NCT05753267

Fenofibrate in Ulcerative Colitis

Fibrates, which are specific pharmacological agonists of PPARα, have been widely used in the treatment of hypercholesterolemia and hypertriglyceridemia. Apart from their metabolic...

Sponsor: Tanta UniversityEnrolling: 601 location
RECRUITINGPhase 3NCT06588855

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in...

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in...

Sponsor: Hoffmann-La RocheEnrolling: 35020 locations
RECRUITINGNCT07191106

Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in...

Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although...

Sponsor: Raincy Montfermeil Hospital GroupEnrolling: 722 locations
RECRUITINGNCT05414578

NORDTREAT Prospective Study on Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), primarily ulcerative colitis (UC) and Crohn's disease (CD), is a chronic disease entity affecting individuals of all ages, and which may severely...

Sponsor: University of Southern DenmarkEnrolling: 80017 locations
RECRUITINGPhase 3NCT07196748

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative...

The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with...

Sponsor: Janssen Research & Development, LLCEnrolling: 88220 locations
RECRUITINGNCT06805890

Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology

Inflammatory Bowel Diseases (IBD) are chronic inflammations of the gastrointestinal tract. Regardless of the etiology, a common trait of IBD pathogenesis is the inflammatory...

Sponsor: Assistance Publique Hopitaux De MarseilleEnrolling: 601 location
RECRUITINGNCT06756100

Early Inflammatory Bowel Disease Progression

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 1401 location
RECRUITINGNCT05615779

Personalized B-fructan Diet in Inflammatory Bowel Disease Patients

This study aims to examine patient tolerability of personalized dietary fibre consumption recommendations (high-pectin diet versus high-B-fructan diet based on personalized...

Sponsor: University of ManitobaEnrolling: 6002 locations
RECRUITINGNCT06698601

Wild Blueberries in Colitis

The goal of this exploratory, prospective, monocentric randomized crossover study is to investigate the influence of a blueberry-rich diet compared to a blueberry-poor diet on the...

Sponsor: Universität Duisburg-EssenEnrolling: 601 location
RECRUITINGPhase 2NCT06029972

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative...

Sponsor: Gilead SciencesEnrolling: 17620 locations
RECRUITINGPhase 2NCT04373473

Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention...

The purpose of the study is to evaluate the efficacy and safety of lyophilized PRIM-DJ2727 capsules given orally in subjects with ulcerative colitis at remission stage. This study...

Sponsor: The University of Texas Health Science Center, HoustonEnrolling: 581 location
RECRUITINGNCT07013578

TIDHI Mental Health in IBD Patients Study

The purpose of this study is to test the impact of Healing Circuits™; a structured mental health support model on IBD patients. The eligible study participants will be randomly...

Sponsor: TIDHI Innovation Inc.Enrolling: 1001 location
RECRUITINGNCT07132333

Molecular Inflammation Board at the Center for Personalized Medicine

Molecular Inflammation Board at the Center for Personalized Medicine

Sponsor: University Hospital TuebingenEnrolling: 30001 location
RECRUITINGNCT06294925

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

The purpose of this real world non-interventional study is to learn about the effects of etrasimod as treatment for patients with moderate to severe ulcerative colitis. Patients...

Sponsor: PfizerEnrolling: 36020 locations
RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT06693310

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

The goal of this study is to better understand treatment strategies for people with ulcerative colitis (UC). Researchers will compare patients with UC in histologic remission (no...

Sponsor: University of ChicagoEnrolling: 2001 location
RECRUITINGNCT07115862

Effects of Pomegranate Juice on Ulcerative Colitis

The purpose of this study is to determine whether consumption of 237 ml of pomegranate juice daily for 8 weeks will: 1. lower inflammation (in the gut as well as generally in the...

Sponsor: University of California, Los AngelesEnrolling: 302 locations
RECRUITINGNCT07314151

Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics...

This study will be conducted at the outpatient clinic of China Medical University hospital. It is expected to enroll two groups of 30 subjects, including the experimental group...

Sponsor: China Medical University HospitalEnrolling: 2001 location
RECRUITINGNCT06906445

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative...

Ulcerative colitis (UC) is a chronic inflammatory disease of the colon characterized by superficial mucosal inflammation. Treatment aims to achieve and maintain remission, improve...

Sponsor: All India Institute of Medical SciencesEnrolling: 2206 locations
RECRUITINGNCT04030676

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

CytoMegaloVirus (CMV) infection impairs evolution of Ulcerative Colitis (UC) leading to more severe and resistant to immunosuppressive therapies flare-up. CytoMegaloVirus (CMV)...

Sponsor: Centre Hospitalier Universitaire de Saint EtienneEnrolling: 1962 locations
RECRUITINGNCT06764706

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe...

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will...

Sponsor: AbbVieEnrolling: 20020 locations
RECRUITINGPhase 3NCT07158242

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to...

This Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and efficacy of Afimkibart (RO7790121) in pediatric participants...

Sponsor: Hoffmann-La RocheEnrolling: 1004 locations
RECRUITINGNCT07237516

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does...

Sponsor: University of North Carolina, Chapel HillEnrolling: 2005 locations
RECRUITINGNCT06538402

Ten Versus Fifteen Centimeter Pouch in IPAA Surgery

The aim of this randomized controlled trial is to compare outcome after construction of an ileal (J-shaped) reservoir of 10 versus 15 centimeters in primary ileal pouch-anal...

Sponsor: Odense University HospitalEnrolling: 1202 locations
RECRUITINGNCT07305454

Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic...

Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies,...

Sponsor: University Hospital, ToulouseEnrolling: 711 location
RECRUITINGNCT06691061

The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis

The goal of this observational study is to compare the real-life effectiveness and safety of vedolizumab, ustekinumab and JAK inhibitors in patients with UC who had been exposed...

Sponsor: Humanitas Clinical and Research CenterEnrolling: 4501 location
RECRUITINGNCT04338204

Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In...

This is a prospective observational study using data from an existing, ongoing National Swedish registry (SWIBREG). This study is designed to assess the effectiveness and...

Sponsor: PfizerEnrolling: 12017 locations
RECRUITINGNCT06576700

Effect of Procyanidins in Leaky Gut Repairing in IBD

The goal of this clinical trial is to learn if the Grape Seed Extract Ecovitis, featuring low monomeric catechins content and a high concentration of oligo-polymeric procyanidins,...

Sponsor: University of PadovaEnrolling: 251 location
RECRUITINGNCT01277419

German Spondyloarthritis Inception Cohort

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA...

Sponsor: Charite University, Berlin, GermanyEnrolling: 10001 location
RECRUITINGNCT07102368

A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated with Guselkumab in a real-world setting, and to assess the...

Sponsor: Janssen-Cilag G.m.b.HEnrolling: 4001 location
RECRUITINGNCT06231264

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

The aim of this study was to evaluate the efficacy and safety of transcutaneous electrical acustimulation in patients with mild to moderate ulcerative colitis.

Sponsor: Xijing HospitalEnrolling: 964 locations
RECRUITINGPhase 3NCT06660693

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

This study aims to examine patients with acute severe UC who are refractory to intravenous corticosteroids and determine whether a strategy of using upadacitinib first followed by...

Sponsor: McMaster UniversityEnrolling: 1341 location
RECRUITINGPhase 4NCT06095128

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative...

Sponsor: TakedaEnrolling: 6520 locations
RECRUITINGPhase 1 / Phase 2NCT07083193

A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of AC-101 tablets in participants with moderate-to-severe ulcerative colitis. The total study...

Sponsor: Accro Bioscience (Suzhou) LimitedEnrolling: 241 location
RECRUITINGNCT05895981

Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.

Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly...

Sponsor: Xijing HospitalEnrolling: 151 location
RECRUITINGNCT06895252

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly...

Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon and rectum, characterized by mucosal inflammation and symptomslike diarrhea, abdominal pain, and...

Sponsor: All India Institute of Medical SciencesEnrolling: 2206 locations
RECRUITINGNCT07141238

Microplastic Analysis in Pediatric Inflammatory Bowel Disease

The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main...

Sponsor: Medical University of GdanskEnrolling: 401 location
RECRUITINGNCT05377840

Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of...

This is a prospective, single center, randomized treatment study to assess if anxiety and depression in participants with IBD can be improved with CBT compared to those treated...

Sponsor: Yale UniversityEnrolling: 1521 location

Showing 50 of 104 trials.Search all Ulcerative Colitis trials

Frequently Asked Questions

There are currently 104 clinical trials for Ulcerative Colitis, with 104 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Ulcerative Colitis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 5 Phase 3 trials for Ulcerative Colitis, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.